サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1324794

RNA分析の世界市場：製品・サービス別、技術別、用途別、エンドユーザー別、地域別-2028年までの予測

RNA Analysis Market by Product, Technology, Application, End User, Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 257 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
RNA分析の世界市場：製品・サービス別、技術別、用途別、エンドユーザー別、地域別-2028年までの予測
出版日: 2023年07月28日
発行: MarketsandMarkets
ページ情報: 英文 257 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のRNA分析の市場規模は、2023年の53億米ドルから2028年には99億米ドルに達すると予測され、予測期間中のCAGRは13.4%と見込まれています。

トランスクリプトミクス研究の分野における進歩、治療薬の成長を支えるトランスクリプトミクス研究の増加によるRNA分析に使用される試薬の需要増加などの要因が、RNA分析製品・サービスの需要を促進しています。

2022年、試薬/消耗品セグメントが最も高い成長率を占めました。製品・サービス市場は、試薬・消耗品、機器、サービス、ソフトウェアに区分されます。治療薬、薬剤設計、遺伝子合成におけるペプチドの用途拡大や、RNA解析を伴う研究プロジェクトの増加が、RNA解析市場における同分野の優位性に寄与しています。

RNA分析市場は、2022年に、北米が圧倒的なシェアを占めました。同地域の大きなシェアは、同地域に大手企業が存在すること、新しいゲノム治療法を開発する研究活動が継続されていることなど、さまざまな要因によるものです。アジア太平洋は、同地域におけるジェネリック医薬品に対する政府のイニシアチブの高まりや、RNA分析市場における新たな市場参入企業の出現などの様々な要因により、より速いペースで成長するとみられています。

当レポートでは、世界のRNA分析市場について調査し、市場の概要とともに、製品・サービス別、技術別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客のビジネスに影響を与える動向/混乱
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • 特許分析
  • 主要特許のリスト
  • 技術分析
  • ポーターのファイブフォース分析
  • 規制分析
  • 2023年の主な会議とイベント
  • 主要な利害関係者と購入基準

第6章 RNA分析市場、製品・サービス別

  • イントロダクション
  • 試薬/消耗品
  • 装置
  • ソフトウェア
  • サービス

第7章 RNA分析市場、技術別

  • イントロダクション
  • ポリメラーゼ連鎖反応
  • シーケンシング
  • マイクロアレイ
  • RNA干渉

第8章 RNA分析市場、用途別

  • イントロダクション
  • 創薬
  • 臨床診断
  • トキシコゲノミクス
  • 比較トランスクリプトミクス

第9章 RNA分析市場、エンドユーザー別

  • イントロダクション
  • 製薬会社およびバイオテクノロジー会社
  • 病院と診断センター
  • 学術研究機関
  • CRO

第10章 RNA分析市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • イントロダクション
  • 主要参入企業が採用した戦略
  • 収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント：主要企業
  • 主要企業25社の競合ベンチマーキング
  • 企業評価クアドラント：スタートアップ/中小企業
  • 新興企業/中小企業の競合ベンチマーキング
  • 競合シナリオと動向

第12章 企業プロファイル

  • 主要参入企業
    • THERMO FISHER SCIENTIFIC INC.
    • F. HOFFMANN-LA ROCHE LTD.
    • BIO-RAD LABORATORIES, INC.
    • ILLUMINA, INC.
    • EUROFINS SCIENTIFIC
    • AGILENT TECHNOLOGIES, INC.
    • CD GENOMICS
    • PROMEGA CORPORATION
    • QIAGEN N.V.
    • DANAHER CORPORATION
    • MERCK KGAA
    • STANDARD BIOTOOLS INC.（FLUIDIGM CORPORATION）
    • SEQUENTIA BIOTECH SL
    • ACOBIOM
    • GENXPRO GMBH
  • その他の企業
    • LEXOGEN GMBH
    • CENIX BIOSCIENCE GMBH
    • TAKARA HOLDINGS INC.
    • BIOMERIEUX SA
    • LC SCIENCES LLC
    • OXFORD NANOPORE TECHNOLOGIES
    • ZYMO RESEARCH CORPORATION
    • GENEDX
    • PARTEK INCORPORATED
    • BGI GROUP

第13章 付録

目次
Product Code: BT 2766

The global RNA analysis market size is projected to reach USD 9.9 billion by 2028 from 5.3 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as the advancements in the field of transcriptomics studies, and the rising demand for reagents used in RNA analysis due to increased transcriptomics studies supporting the growth of therapeutics are driving the demand for RNA analysis products & services.

"The reagents/consumables segment accounted for the highest growth rate in the RNA analysis market, by product & service, during the forecast period"

In 2022, the reagents/consumables segment accounted for the highest growth rate. The product & service market is segmented into reagents/consumables, instruments, services, and software. Expanding applications of peptides in therapeutics, drug design, and gene synthesis and the growing number of ongoing research projects involving RNA analysis contributes to the segment's prominence in the RNA analysis market.

"Asia Pacific region is likely to grow at a faster pace."

The RNA analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the RNA analysis market. The large share of the region is attributable to various factors such as the presence of leading players in the region paired with the continuing research activities of developing new genomic therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as rising government initiatives for generic medicines in the region, and the emergence of new market players in the RNA analysis market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Bio-Rad Laboratories, Inc. (US)
  • Illumina, Inc. (US)
  • Eurofins Scientific (Luxembourg)
  • Agilent Technologies, Inc. (US)
  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Promega Corporation (US)
  • QIAGEN N.V. (Germany)
  • Standard BioTools (US)
  • Sequentia Biotech SL (Spain)
  • Acobiom (France)
  • GenXPro GmbH (Germany)
  • CD Genomics (US)
  • Promega Corporation (US)
  • Lexogen GmbH (Austria)
  • Cenix BioScience GmbH (Germany)
  • Takara Holdings, Inc. (Japan)
  • bioMerieux SA (France)
  • LC Sciences LLC (US)
  • Oxford Nanopore Technologies (UK)
  • Zymo Research Corporation (US)
  • GeneDx (US)
  • Partek Incorporated (US)
  • BGI Group (China)

Research Coverage:

This report provides a detailed picture of the RNA analysis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall RNA analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing demand for personalized medicine, Rising pharmaceutical and biotechnology R&D expenditure and government funding, and the Increasing applications of RNA sequencing in transcriptomics), restraints (High capital investments), opportunities (High growth opportunities in emerging markets, Increasing applications in toxicogenomics, Increasing focus on biomarker discovery, Rising focus on outsourcing), and challenges (Data management in transcriptomics research, Lack of effective bioinformatics tools, Dearth of skilled professionals.)
  • Product & Service Development/Innovation: Detailed insights on newly launched products/services, and technological assessment of the RNA analysis market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the RNA analysis market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the RNA analysis market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), and among others in the RNA analysis market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 RNA ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 RNA ANALYSIS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022)
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
    • 2.2.1 INSIGHTS FROM PRIMARIES
    • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
    • 2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, TECHNOLOGY, APPLICATION, AND END USER)
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH RATE ASSUMPTIONS
    • FIGURE 8 RNA ANALYSIS MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 9 RNA ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 IMPACT OF ECONOMIC RECESSION ON RNA ANALYSIS MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024-2028 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 11 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 RNA ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 RNA ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT: RNA ANALYSIS MARKET

4 PREMIUM INSIGHTS

  • 4.1 RNA ANALYSIS MARKET OVERVIEW
    • FIGURE 16 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: RNA ANALYSIS MARKET SHARE, BY APPLICATION & COUNTRY (2022)
    • FIGURE 17 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RNA ANALYSIS MARKET IN 2022
  • 4.3 RNA ANALYSIS MARKET SHARE, BY END USER, 2022
    • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.4 RNA ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RNA ANALYSIS MARKET FROM 2023 TO 2028
  • 4.5 RNA ANALYSIS MARKET, BY REGION (2023-2028)
    • FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE RNA ANALYSIS MARKET UNTIL 2028
  • 4.6 RNA ANALYSIS MARKET: DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 RNA ANALYSIS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for personalized medicine
    • FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015-2022
      • 5.2.1.2 Rising pharmaceutical and biotechnology R&D expenditure and government funding
    • FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2026
      • 5.2.1.3 Increasing applications of RNA sequencing in transcriptomics
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital investments
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth opportunities in emerging markets
      • 5.2.3.2 Increasing applications in toxicogenomics
      • 5.2.3.3 Increasing focus on biomarker discovery
      • 5.2.3.4 Rising focus on outsourcing
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Data management in transcriptomics research
      • 5.2.4.2 Lack of effective bioinformatics tools
      • 5.2.4.3 Dearth of skilled professionals
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS OF RNA ANALYSIS MARKET: RESEARCH AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 RNA ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • TABLE 5 SUPPLY CHAIN ECOSYSTEM
  • 5.7 PATENT ANALYSIS
    • FIGURE 27 PATENT APPLICATIONS FOR RNA ANALYSIS MARKET, JUNE 2012-JUNE 2023
  • 5.8 LIST OF MAJOR PATENTS
  • 5.9 TECHNOLOGY ANALYSIS
    • TABLE 6 COMPARISON OF MODERN RNA ANALYSIS METHODS
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 RNA ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATIONS FOR RNA ANALYSIS PRODUCTS
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 11 RNA ANALYSIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RNA ANALYSIS PRODUCTS
    • 5.13.2 BUYING CRITERIA
    • FIGURE 29 KEY BUYING CRITERIA FOR END USERS

6 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 12 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 REAGENTS/CONSUMABLES
    • 6.2.1 REAGENTS/CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 13 RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 14 NORTH AMERICA: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 15 EUROPE: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 GROWING NEED FOR ACCURATE ANALYSIS TO DRIVE ADOPTION OF AUTOMATED INSTRUMENTS
    • TABLE 17 RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 NORTH AMERICA: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 EUROPE: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 SOFTWARE
    • 6.4.1 GROWING NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS TO DRIVE DEMAND FOR SOFTWARE SOLUTIONS
    • TABLE 21 RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 NORTH AMERICA: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 EUROPE: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5 SERVICES
    • 6.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH
    • TABLE 25 RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 NORTH AMERICA: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 EUROPE: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 ASIA PACIFIC: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 RNA ANALYSIS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 29 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 7.2 POLYMERASE CHAIN REACTION
    • 7.2.1 ABILITY OF REAL-TIME PCR TO AID IN QUANTIFICATION OF LOW-COPY TRANSCRIPTS TO BOOST DEMAND
    • TABLE 30 RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 SEQUENCING
    • 7.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH
    • TABLE 34 RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 EUROPE: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 MICROARRAYS
    • 7.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
    • TABLE 38 RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 EUROPE: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 RNA INTERFERENCE
    • 7.5.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT ADOPTION OF TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS
    • TABLE 42 RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)

8 RNA ANALYSIS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 46 RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 DRUG DISCOVERY
    • 8.2.1 GROWING POPULARITY OF TARGETED SEQUENCING-BASED APPROACHES IN DRUG DISCOVERY TO BOOST MARKET
    • TABLE 47 RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 EUROPE: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CLINICAL DIAGNOSTICS
    • 8.3.1 GROWING ADOPTION OF TRANSCRIPTOMICS FOR LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS TO FUEL GROWTH
    • TABLE 51 RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 TOXICOGENOMICS
    • 8.4.1 GROWING FOCUS ON ADR STUDIES TO DRIVE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY
    • TABLE 55 RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 56 NORTH AMERICA: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 EUROPE: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 ASIA PACIFIC: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 COMPARATIVE TRANSCRIPTOMICS
    • 8.5.1 WIDE ADOPTION OF TRANSCRIPTIONAL PROFILES TO STUDY EVOLUTION AMONG SPECIES TO PROPEL GROWTH
    • TABLE 59 RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 60 NORTH AMERICA: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 EUROPE: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021-2028 (USD MILLION)

9 RNA ANALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 63 RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS TO DRIVE USE OF OMICS TECHNOLOGIES IN PHARMA & BIOTECH COMPANIES
    • TABLE 64 RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 HOSPITALS & DIAGNOSTIC CENTERS
    • 9.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS TO FAVOR MARKET GROWTH
    • TABLE 68 RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
    • TABLE 72 RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 CONTRACT RESEARCH ORGANIZATIONS
    • 9.5.1 GROWING OUTSOURCING OF SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY TO AID MARKET GROWTH
    • TABLE 76 RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 77 NORTH AMERICA: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

10 RNA ANALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 80 RNA ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: RNA ANALYSIS MARKET SNAPSHOT
    • TABLE 81 NORTH AMERICA: RNA ANALYSIS MARKET, BY COUNTRY, 2021-2028(USD MILLION)
    • TABLE 82 NORTH AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 84 NORTH AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 85 NORTH AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate North American RNA analysis market during forecast period
    • TABLE 86 US: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 87 US: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 88 US: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 89 US: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Improving funding and infrastructure for omics-based research to support market growth
    • TABLE 90 CANADA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 91 CANADA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 92 CANADA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 93 CANADA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 94 EUROPE: RNA ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 96 EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 97 EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany to hold largest share of European RNA analysis market during forecast period
    • TABLE 99 GERMANY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 100 GERMANY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 101 GERMANY: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 102 GERMANY: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising public and private funding for research to drive market growth
    • TABLE 103 UK: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 104 UK: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 105 UK: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 106 UK: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing government support for omics-based research to support market growth
    • TABLE 107 FRANCE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 108 FRANCE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 109 FRANCE: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 110 FRANCE: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Improving R&D expenditure and disease diagnostics to boost market
    • TABLE 111 ITALY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 112 ITALY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 113 ITALY: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 114 ITALY: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing collaborations for enhancing research to support market growth
    • TABLE 115 SPAIN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 116 SPAIN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 117 SPAIN: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 118 SPAIN: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 SWITZERLAND
      • 10.3.6.1 Well-established pharmaceutical industry to drive market growth
    • TABLE 119 SWITZERLAND: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 120 SWITZERLAND: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 121 SWITZERLAND: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 122 SWITZERLAND: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 123 REST OF EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 124 REST OF EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 125 REST OF EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 126 REST OF EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 EUROPE: RECESSION IMPACT
  • 10.5 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: RNA ANALYSIS MARKET SNAPSHOT
    • TABLE 127 ASIA PACIFIC: RNA ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 CHINA
      • 10.5.1.1 China to be fastest-growing market in Asia Pacific during forecast period
    • TABLE 132 CHINA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 133 CHINA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 134 CHINA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 135 CHINA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 JAPAN
      • 10.5.2.1 Early adoption of technologically advanced products to drive market growth
    • TABLE 136 JAPAN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 137 JAPAN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 138 JAPAN: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 139 JAPAN: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 INDIA
      • 10.5.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth
    • TABLE 140 INDIA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 141 INDIA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 142 INDIA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 143 INDIA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.4 REST OF ASIA PACIFIC
    • TABLE 144 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 145 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 146 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.6 ASIA PACIFIC: RECESSION IMPACT
  • 10.7 LATIN AMERICA
    • 10.7.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
    • TABLE 148 LATIN AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 149 LATIN AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 150 LATIN AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 151 LATIN AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.8 LATIN AMERICA: RECESSION IMPACT
  • 10.9 MIDDLE EAST & AFRICA
    • 10.9.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS TO DRIVE MARKET GROWTH
    • TABLE 152 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 153 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 154 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 155 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.10 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 32 RNA ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
    • TABLE 156 RNA ANALYSIS MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
    • FIGURE 35 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 11.6.1 COMPANY PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 157 COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
    • 11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 158 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
  • 11.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
    • FIGURE 36 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/ SMES, 2022
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
  • 11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
    • TABLE 159 RNA ANALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 160 RNA ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 161 RNA ANALYSIS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020-JUNE 2023
    • 11.9.2 DEALS
    • TABLE 162 RNA ANALYSIS MARKET: DEALS, JANUARY 2020-JUNE 2023
    • 11.9.3 OTHER DEVELOPMENTS
    • TABLE 163 RNA ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020-JUNE 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • TABLE 164 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • 12.1.2 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 165 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 38 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 12.1.3 BIO-RAD LABORATORIES, INC.
    • TABLE 166 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.4 ILLUMINA, INC.
    • TABLE 167 ILLUMINA, INC.: COMPANY OVERVIEW
    • FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.5 EUROFINS SCIENTIFIC
    • TABLE 168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 12.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 169 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.7 CD GENOMICS
    • TABLE 170 CD GENOMICS: COMPANY OVERVIEW
    • 12.1.8 PROMEGA CORPORATION
    • TABLE 171 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 12.1.9 QIAGEN N.V.
    • TABLE 172 QIAGEN N.V.: COMPANY OVERVIEW
    • FIGURE 43 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
    • 12.1.10 DANAHER CORPORATION
    • TABLE 173 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.11 MERCK KGAA
    • TABLE 174 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 12.1.12 STANDARD BIOTOOLS INC. (FLUIDIGM CORPORATION)
    • TABLE 175 STANDARD BIOTOOLS INC.: BUSINESS OVERVIEW
    • FIGURE 46 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT (2022)
    • 12.1.13 SEQUENTIA BIOTECH SL
    • TABLE 176 SEQUENTIA BIOTECH SL: BUSINESS OVERVIEW
    • 12.1.14 ACOBIOM
    • TABLE 177 ACOBIOM: BUSINESS OVERVIEW
    • 12.1.15 GENXPRO GMBH
    • TABLE 178 GENXPRO GMBH: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 LEXOGEN GMBH
    • 12.2.2 CENIX BIOSCIENCE GMBH
    • 12.2.3 TAKARA HOLDINGS INC.
    • 12.2.4 BIOMERIEUX SA
    • 12.2.5 LC SCIENCES LLC
    • 12.2.6 OXFORD NANOPORE TECHNOLOGIES
    • 12.2.7 ZYMO RESEARCH CORPORATION
    • 12.2.8 GENEDX
    • 12.2.9 PARTEK INCORPORATED
    • 12.2.10 BGI GROUP
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS